The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Decreased content, rate of synthesis and export of cholesterol in the brain of apoE knockout mice
Abstract
Apolipoprotein E knockout (apoE-KO) mice present synaptic loss, cognitive dysfunction, and high plasma lipid levels that may affect brain function simulating Alzheimer disease. Plasma and brain sterols were measured in apoE-KO and in wild type control mice on a cholesterol-free, phytosterol-containing diet by gas chromatography coupled to a mass spectrometer. Plasma cholesterol and phytosterols (campesterol and sitosterol) were higher in apoE-KO compared to control mice. Cholesterol precursors (desmosterol and lathosterol) were not detected in plasma of control mice but were present in apoE-KO mice. In the brain amounts of cholesterol, desmosterol, campesterol and 24-hydroxycholesterol were significantly lower in apoE-KO than in controls. There is a tendency in apoE-KO for lower values of 7α-hydroxycholesterol and 7β-hydroxycholesterol. Cholesterol content, synthesis rates (desmosterol) and export of 24-hydroxycholesterol are reduced in the brain of the severe hypercholesterolemic apoE-KO mice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In adulthood, astrocytes synthesize most brain cholesterol.
“Of note, in adulthood astrocytes are believed to synthetize most cholesterol, which is transferred to the neurons via ApoE-containing lipoproteins 3,10 .”
From SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington’s disease phenotypes (2021) · cites this paper as [10]
Astrocyte-derived cholesterol is transferred to neurons via ApoE-containing lipoproteins.
“Of note, in adulthood astrocytes are believed to synthetize most cholesterol, which is transferred to the neurons via ApoE-containing lipoproteins 3,10 .”
From SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington’s disease phenotypes (2021) · cites this paper as [10]
Citations
Cites
Michikawa, M., Fan, Q., Isobe, I., & Yanagisawa, K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741008.x · Cited by 244
Flagged first, then by citations
Research works printed but not linked: 33
- Bandaru VV, Troncoso J, Wheeler D, Pletnikova O, Wang J, Conant K, Haughey NJ (2009) ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain. Neurobiol Aging 30:591–599 · DOI
- Björkhem I, Lütjohann D, Diczfalusy U, Ståhle L, Ahlborg G, Wahren J (1998) Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res 39:1594–1600 · DOI · Paper page
- Björkhem I, Andersson U, Ellis E, Alvelius G, Ellegard L, Diczfalusy U, Sjovall J, Einarsson C (2001) From brain to bile. Evidence that conjugation and omega-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans. J Biol Chem 276:37004–37010 · DOI
- Burns MP, Noble WJ, Olm V, Gaynor K, Casey E, LaFrancois J, Wang L, Duff K (2003) Co-localization of cholesterol, apolipoprotein E and fibrillar Abeta in amyloid plaques. Brain Res Mol Brain Res 110:119–125 · DOI
- Chobanian AV, Hollander W (1962) Body cholesterol metabolism in man. I. The equilibration of serum and tissue cholesterol. J Clin Invest 41:1732–1737 · DOI
- Dietschy JM, Turley SD (2004) Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45:1375–1397 · DOI · Paper page
- Dzeletovic S, Breuer O, Lund E, Diczfalusy U (1995) Determination of cholesterol oxidation products in human plasma by isotope dilution mass spectrometry. Anal Biochem 225:73–80 · DOI
- Ferreira GS, Pinto PR, Iborra RT, Del Bianco V, Santana MFM, Nakandakare ER et al (2017) Aerobic exercise training selectively changes oxysterol levels and metabolism reducing cholesterol accumulation in the aorta of Dyslipidemic mice. Front Physiol 8:644 · DOI
- Haines TH (2001) Do sterols reduce proton and sodium leaks through lipid bilayers? Prog Lipid Res 40:299–324 · DOI
- Hossain MA, Tsujita M, Akita N, Kobayashi F, Yokoyama S (2009) Cholesterol homeostasis in ABCA1/LCAT double-deficient mouse. Biochim Biophys Acta 1791:1197–2059 · DOI
- Jenner AM, Lim WL, Ng MP, Wenk MR, Shui G, Sharman MJ et al (2010) The effect of APOE genotype on brain levels of oxysterols in young and old human APOE epsilon2, epsilon3 and epsilon4 knock-in mice. Neuroscience 169:109–115 · DOI
- Kivipelto M, Helkala EL, Hänninen T, Laakso MP, Hallikainen M, Alhainen K et al (2001) Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 56:1683–1689 · DOI · Paper page
- Kruit JK, Groen AK, van Berkel TJ, Kuipers F (2006) Emerging roles of the intestine in control of cholesterol metabolism. World J Gastroenterol 12(40):6429–6439 · DOI
- Ledesma MD, Dotti CG (2006) Amyloid excess in Alzheimer's disease: what is cholesterol to be blamed for? FEBS Lett 580:5525–5532 · DOI
- Ledesma MD, Abad-Rodriguez J, Galvan C, Biondi E, Navarro P, Delacourte A, Dingwall C, Dotti CG (2003) Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains. EMBO Rep 4:1190–1196 · DOI
- Lee J, Choi J, Wong GW, Wolfgang MJ (2016) Neurometabolic roles of ApoE and Ldl-R in mouse brain. J Bioenerg Biomembr 48:13–21 · DOI · Paper page
- Leoni V, Solomon A, Kivipelto M (2010) Links between ApoE, brain cholesterol metabolism, tau and amyloid β-peptide in patients with cognitive impairment. Biochem Soc Trans 38(4):1021–1025 · DOI
- Lütjohann D, Breuer O, Ahlborg G, Nennesmo I, Sidén A, Diczfalusy U et al (1996) Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci U S A 93:9799–9804 · DOI · Paper page
- Lütjohann D, Harzer K, Gieselmann V, Eckhardt M (2006) Reduced brain cholesterol content in arylsulfatase A-deficient mice. Biochem Biophys Res Commun 344:647–650 · DOI
- Masliah E, Mallory M, Ge N, Alford M, Veinbergs I, Roses AD (1995) Neurodegeneration in the central nervous system of apoE-deficient mice. Exp Neurol 136:107–122 · DOI
- Mauch DH, Nägler K, Schumacher S, Göritz C, Müller EC, Otto A, Pfrieger FW (2001) CNS synaptogenesis promoted by glia-derived cholesterol. Science 294:1354–1357 · DOI · Paper page
- Meljon A, Wang Y, Griffiths WJ (2014) Oxysterols in the brain of the cholesterol 24-hydroxylase knockout mouse. Biochem Biophys Res Commun 446:768–774 · DOI
- Nunes VS, Leança CC, Panzoldo NB, Parra E, Cazita PM, Nakandakare ER, de Faria EC, Quintão ECR (2011) HDL-C concentration is related to markers of absorption and of cholesterol synthesis: study in subjects with low vs. high HDL-C. Clin Chim Acta 412:176–180 · DOI
- Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71:343–353 · DOI · Paper page
- Quan G, Xie C, Dietschy JM, Turley SD (2003) Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. Brain Res Dev Brain Res 146:87–98 · DOI · Paper page
- Reeves PG (1997) Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr 127:838S–841S · DOI
- Russell DW, Halford RW, Ramirez DM, Shah R, Kotti T (2009) Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. Annu Rev Biochem 78:1017–1040 · DOI · Paper page
- Sparks DL, Scheff SW, Hunsaker JC 3rd, Liu H, Landers T, Gross DR (1994) Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 126:88–94 · DOI · Paper page
- Thelen KM, Falkai P, Bayer TA, Lütjohann D (2006) Cholesterol synthesis rate in human hippocampus declines with aging. Neurosci Lett 403:15–19 · DOI · Paper page
- Valenza M, Leoni V, Tarditi A, Mariotti C, Björkhem I, Di Donato S, Cattaneo E (2007) Progressive dysfunction of the cholesterol biosynthesis pathway in the R6/2 mouse model of Huntington's disease. Neurobiol Dis 28:133–142 · DOI · Paper page
- Walker LC, Parker CA, Lipinski WJ, Callahan MJ, Carroll RT, Gandy SE, Smith JD, Jucker M, Bisgaier CL (1997) Cerebral lipid deposition in aged apolipoprotein-E-deficient mice. Am J Pathol 151:1371–1377
- Zatta P, Zambenedetti P, Stella MP, Licastro F (2002) Astrocytosis, microgliosis, metallothionein-I-II and amyloid expression in high cholesterol-fed rabbits. J Alzheimers Dis 4:1–9 · DOI
- Zhang SH, Reddick RL, Piedrahita JA, Maeda N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258:468–471 · DOI · Paper page
Cited by
Sorted by citations
Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease
Marais, A. D. (2019) · Pathology · doi:10.1016/j.pathol.2018.11.002 · Cited by 382
Fernandez, C. G., Hamby, M. E., McReynolds, M. L., & Ray, W. J. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00014 · Cited by 277
Brain cell type-specific cholesterol metabolism and implications for learning and memory
Li, D., Zhang, J., & Liu, Q. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.01.002 · Cited by 163
SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington’s disease phenotypes
Birolini, G., Verlengia, G., Talpo, F., Maniezzi, C., Zentilin, L., Giacca, M., Conforti, P., Cordiglieri, C., Caccia, C., Leoni, V., et al. (2021) · Brain · doi:10.1093/brain/awab186 · Cited by 48
Testa, G., Giannelli, S., Staurenghi, E., Cecci, R., Floro, L., Gamba, P., Sottero, B., & Leonarduzzi, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413637 · Cited by 14
“On the one hand, it has been reported that brain cholesterol synthesis and amount significantly decreased in ApoE knock-out mice, an AD-simulating model characterized by synaptic loss and cognitive dysfunction [7].”
Metadata
- Authors
- Nunes, V. S., Cazita, P. M., Catanozi, S., Nakandakare, E. R., & Quintão, E. C. R.
- Venue
- Journal of Bioenergetics and Biomembranes
- Published
- 2018-04-20
- Volume
- 50
- Issue
- 4
- Pages
- 283-287
- ISSN
- 0145-479X
- 1573-6881
- Cited by
- 32
- References
- 1
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
- Funders
- São Paulo Research Foundation (2015-17566-2)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review